Knockdown of Fzd3 was found to reverse HCC resistance to cisplatin and adriamycin chemotherapy by inhibiting the Wnt/β-catenin signaling pathway in HCC [61]. The gene discussed is FZD3; the disease is hepatocellular carcinoma.